Loading…

Teleflex announced on December 29, 2020, that it has completed its previously announced acquisition of hemostatic product maker Z-Medica for an upfront cash payment of $500 million, with up to an additional $25 million upon achieving certain commercial milestones.
“Teleflex (NYSE: TFX) announced that it has completed its previously announced acquisition of hemostatic product maker Z-Medica.”medicaldesignandoutsourcing.com
Summarized from public sources; check the original articles before acting on it.